Changzhou Pharmaceutical e fumane tumello ea ho hlahisa Lenalidomide Capsules

Changzhou Pharmaceutical Factory Ltd.,lekalana la Shanghai Pharmaceutical Holdings, le amohetse Setifikeiti sa Ngoliso ea Lithethefatsi (Setifikeiti sa No. 2021S01077, 2021S01078, 2021S01079) se fanoeng ke Tsamaiso ea Naha ea Lithethefatsi bakeng saLi-capsules tsa Lenalidomide(Specification 5mg, 10mg, 25mg), e ileng ea amoheloa bakeng sa tlhahiso.
Lintlha tsa motheo
Lebitso la lithethefatsi:Li-capsules tsa Lenalidomide
Foromo ea litekanyetso:Capsule
Tlhaloso:5mg, 10mg, 25mg
Sehlopha sa ho ingolisa:Sehlopha sa 4 sa lithethefatsi tsa lik'hemik'hale
Nomoro ea sehlopha:State Drug Certificate H20213802, State Drug Certificate H20213803, State Drug Certificate H20213804
Qeto ea tumello: Kopana le litlhoko tsa ngoliso ea lithethefatsi, e amohetsoeng bakeng sa ho ngolisoa, e fane ka setifikeiti sa ngoliso ea lithethefatsi.
Lintlha tse amanang
Lenalidomideke moloko o mocha oa sethethefatsi sa oral immunomodulatory se nang le ts'ebetso ea ho thibela ho ata ha lisele tsa hlahala, ho etsa hore tumor cell apoptosis le immunomodulation, e sebelisoang haholo ho phekola lefu la myeloma le myelodysplastic (MDS) le maemo a mang.E sebelisoa hammoho le dexamethasone ho phekola bakuli ba baholo ba nang le myeloma e mengata eo pele e neng e sa phekoloe bao e seng baemeli ba transplantation.Sehlahisoa sena se sebelisoa hammoho le dexamethasone ho phekola bakuli ba baholo ba nang le myeloma e mengata ba fumaneng bonyane phekolo e le 'ngoe ea pele.Sehlahisoa sena se sebelisoa hammoho le rituximab ho phekola bakuli ba baholo ba follicular lymphoma (lihlopha tsa 1-3a) ba fumaneng phekolo ea pele.
Li-capsules tsa Lenalidomide li qalile ho hlahisoa ke Celgene Biopharmaceuticals 'me tsa rekisoa US ka 2005. ka December 2019, Changzhou Pharmaceutical Factory e ile ea kenya kopo ea ho ngolisa le ho bapatsa ho State Drug Administration bakeng sa moriana, o ileng oa amoheloa.
Lintlha tse tsoang Minene.com li bontša hore thekiso ea naha ea li-capsules tsa Nalidomide ka 2020 e tla ba hoo e ka bang RMB 1.025 limilione tse likete.
Ho latela maano a naha a amehang, mefuta e fapaneng ea litlhare tse tloaelehileng tse amohetsoeng ho latela mofuta o mocha oa ngoliso e tla fumana tšehetso e kholoanyane libakeng tse kang tefo ea inshorense ea bongaka le theko ea thepa ea setsi sa bongaka.Ka hona, tlhahiso e amohelehang eaChangzhou Pharmaceutical Factory's lenalidomidecapsule e thusa ho tsoela pele ho holisa karolo ea eona ea mmaraka lefapheng la kalafo ea hematology-tumor le ho ntlafatsa tlholisano ea eona ea mebaraka, hammoho le ho bokella boiphihlelo ba bohlokoa bakeng sa lihlahisoa tse latelang tsa k'hamphani ho ntšetsa pele nts'etsopele ea lithethefatsi tse tloaelehileng le ho ngolisa ngoliso.


Nako ea poso: Nov-09-2021